This session will present the findings from an online survey of medical and pharmacy directors of US health plans, insurers, and pharmacy benefit managers (PBMs) that covered how comparative effectiveness research (CER) and evidence-based medicine (EBM) results are incorporated into a Pharmacy and Therapeutics (P&T) Committee's decision-making process. The speakers will also provide a pharma and a US health plan perspective on partnering with health plans and payers to develop and disseminate EBM and CER information, challenges with communicating these results, and strategies to address these challenges.